Expanded indication for Evicel

The FDA has approved the use of Omrix Biopharmaceuticals' Evicel (human liquid fibrin sealant) for general hemostasis in surgery.Evicel is an aprotinin-free formulation indicated as an adjunct to hemostasis when the control of bleeding by standard surgical techniques is either ineffective or impractical. In the clinical studies supporting the approval, Evicel effectively controlled surgical bleeding in three different surgical procedures including soft tissue bleeding during retroperitoneal or intra-abdominal surgery.

For more information call (800) USE-ENDO or visit www.evicel.com.